Skip to main content
Year archive

Moberg Pharma — 2023 filings

All 56 regulatory filings released by Moberg Pharma (MOB) in 2023, sourced directly from the official regulator.

56 Filings
2023 Period
2023 filings (56)
Filing Released Lang
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-07 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-07 English
Moberg Pharma strengthens the organization
Board/Management Information
2023-11-07 English
Moberg Pharma förstärker organisationen och genomför ledningsförändringar
Board/Management Information
2023-11-07 Swedish
Moberg Pharmas valberedning utsedd
Governance Information
2023-10-17 Swedish
Moberg Pharma’s Nomination Committee appointed
Board/Management Information
2023-10-17 English
Kommuniké från Moberg Pharmas Extra Bolagsstämma
Share Issue/Capital Change
2023-10-09 Swedish
Bulletin from Moberg Pharma´s Extraordinary General Meeting
AGM Information
2023-10-09 English
Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America
Legal Proceedings Report
2023-10-06 English
Moberg Pharma har slutfört rekryteringen till fas 3-studien för MOB-015 i Nordamerika
Regulatory Filings
2023-10-06 Swedish
Förändring av antalet aktier och röster i Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-09-29 Swedish
New number of shares and votes in Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-09-29 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-09-15 English
Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
AGM Information
2023-09-13 English
Kallelse till extra bolagsstämma i Moberg Pharma AB (publ)
AGM Information
2023-09-13 Swedish
Clarification regarding directed issue of units to guarantors in connection with the completed rights issue
Share Issue/Capital Change
2023-09-13 English
Förtydligande avseende riktad emission av units till garanter i samband med genomförd företrädesemission
Share Issue/Capital Change
2023-09-13 Swedish
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-09-12 English
Moberg Pharma genomför riktad emission av units till garanter i samband med den genomförda företrädesemissionen
Capital/Financing Update
2023-09-08 Swedish
Moberg Pharma resolves a directed issue of units to guarantors in connection with the completed rights issue
Capital/Financing Update
2023-09-08 English
Moberg Pharma’s rights issue of MSEK 100 is oversubscribed – subscription rate 130%
Capital/Financing Update
2023-09-01 English
Moberg Pharmas företrädesemission om 100 MSEK är övertecknad – teckningsgrad 130%
Capital/Financing Update
2023-09-01 Swedish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-25 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-21 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-18 English
MOBERG PHARMA OFFENTLIGGÖR PROSPEKT AVSEENDE FÖRETRÄDESEMISSIONEN
Capital/Financing Update
2023-08-14 Swedish
MOBERG PHARMA PUBLISHES PROSPECTUS RELATING TO THE RIGHTS ISSUE
Capital/Financing Update
2023-08-14 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-11 English
Bulletin from Moberg Pharma´s Extraordinary General Meeting on August 8, 2023
AGM Information
2023-08-08 English
Kommuniké från Moberg Pharmas extra bolagsstämma den 8 augusti 2023
Share Issue/Capital Change
2023-08-08 Swedish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-08 English
MOBERG PHARMA OFFENTLIGGÖR DE SLUTLIGA VILLKOREN FÖR FÖRETRÄDESEMISSIONEN
Capital/Financing Update
2023-08-04 Swedish
MOBERG PHARMA ANNOUNCES THE FINAL TERMS OF THE RIGHTS ISSUE
Capital/Financing Update
2023-08-04 English
Interim / Quarterly Report 2023
Interim / Quarterly Report H2 2023
2023-08-03 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report H2 2023
2023-08-03 English
Förändring av antalet aktier och röster i Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-06-30 Swedish
New number of shares and votes in Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-06-30 English
Kallelse till extra bolagsstämma i Moberg Pharma AB (publ)
AGM Information
2023-06-28 Swedish
Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
AGM Information
2023-06-28 English
Moberg Pharma resolves on a rights issue of approximately SEK 100 million
Capital/Financing Update
2023-06-28 English
Moberg Pharma beslutar om en företrädesemission om cirka 100 MSEK
Capital/Financing Update
2023-06-28 Swedish
MOB-015 rekommenderas för marknadsgodkännande i EU
Regulatory Filings
2023-06-28 Swedish
MOB-015 is recommended for approval in EU
Regulatory Filings
2023-06-28 English
The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares
Share Issue/Capital Change
2023-06-05 English
Styrelsen utnyttjar emissions- och återköpsbemyndiganden samt omvandlar C-aktier till stamaktier
Capital/Financing Update
2023-06-05 Swedish
Förändring av antalet aktier och röster i Moberg Pharma AB (publ)
Share Issue/Capital Change
2023-05-31 Swedish
New number of shares and votes in Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2023-05-31 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-09 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-09 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-18 Swedish
Notice of Annual General Meeting in Moberg Pharma AB (publ)
AGM Information
2023-04-05 English
Kallelse till årsstämma i Moberg Pharma AB (publ)
AGM Information
2023-04-05 Swedish
Moberg Pharma får tillbaka fullständiga rättigheter för MOB-015 i Japan
M&A Activity
2023-03-09 Swedish
Moberg Pharma regains full rights to MOB-015 in Japan
M&A Activity
2023-03-09 English
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-02-07 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-02-07 English